Corporate News 05-Feb-24
Board of Zydus Lifesciences to consider buyback of shares
On 09 February 2024
The Board of Zydus Lifesciences will meet on 09 February 2024 to consider a proposal for buyback of shares.
Previous News
Zydus completes Phase II clinical study of NLRP3 inhibitor ‘Usnoflast (ZYIL1)'
( Corporate News - 24-May-24 16:02 )
Zydus Lifesciences receives USFDA approval for Scopolamine Transdermal System
( Corporate News - 30-Aug-24 15:12 )
Barometers end with minor gains; broader mkt outperforms
( Market Commentary - Quick Review 18-May-24 12:44 )
Zydus Life Jarod facility receives USFDA warning letter
( Hot Pursuit - 30-Aug-24 15:11 )
Zydus Life gains on USFDA nod for phase 2 clinical trial of ZYIL1
( Hot Pursuit - 18-Dec-23 09:22 )
Zydus Life spurts on reporting robust Q4 numbers
( Hot Pursuit - 18-May-24 11:41 )
Zydus receives USFDA approval for Zituvimet™ XR tablets
( Corporate News - 19-Jul-24 13:58 )
Zydus Life gets USFDA nod for Zituvimet XR tablets
( Hot Pursuit - 19-Jul-24 11:53 )
Zydus completes acquisition of 50% stake in Sterling Biotech
( Corporate News - 30-Aug-24 11:21 )
Zydus Lifesciences consolidated net profit rises 53.24% in the September 2023 quarter
( Results - Announcements 07-Nov-23 12:50 )
Zydus receives USFDA warning for injectables manufacturing unit at Jarod
( Corporate News - 30-Aug-24 14:49 )
Other Stories
GAIL (India) signs MoU with AM Green
04-Oct-24 19:27
EaseMyTrip.com resumes bookings to the Maldives
04-Oct-24 19:25
BLS completes acquisition of Dubai-based Citizenship Invest
04-Oct-24 19:23
Insecticides India launches new maize herbicide 'Torry Super'
04-Oct-24 19:21
Landmark Cars receives LoI from Mercedes-Benz India
04-Oct-24 19:19
Astra Microwave Products receives affirmation in credit ratings from CRISIL
04-Oct-24 19:16
Supreme Petrochem receives affirmation in credit ratings
04-Oct-24 19:10
Astec LifeSciences director resigns
04-Oct-24 19:08
Board of Gravita India approves change in directorate
04-Oct-24 19:05
Board of Gravita India approves fund raising up to Rs 1,000 cr
04-Oct-24 19:03
Back
Top
